drugset

drugset / Trial / NCT04297033

Lovastatin for Treatment of Brain Arteriovenous Malformations

NCT04297033 ↗

Phase 2 Unknown 1244 enrolled Beijing Tiantan Hospital

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this pilot study is to evaluate the disease-modifying efficacy of lovastatin in patients with brain arteriovenous malformation.

Timeline

Start: 2021-01-01
Primary completion: 2024-06-01
Completion: 2024-06-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lovastatin	Small molecule	40 mg	—

Indications